TMEM127
protein-codingtransmembrane protein 127
Gene summary
This gene encodes a transmembrane protein with four predicted transmembrane domains. The protein is associated with a subpopulation of vesicular organelles corresponding to early endosomal structures, with the Golgi, and with lysosomes, and may participate in protein trafficking between these structures. Mutations in this gene and several other genes cause pheochromocytomas. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Aug 2022]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008233
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0008233
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0008233
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0017366
Submitter: ClinGen
Hereditary Paraganglioma-Pheochromocytoma Syndromes (PGL/PCC) [MONDO:0017366, PMID: 20301715] describes susceptibility to Paraganglioma such as head and neck, retroperitoneum [PMID: 21613359], or Renal cell carcinomas (RCCs) [PMID 24334765] and Pheochromocytoma [MIM#171300, PMID: 21156949] with autosomal dominant inheritance. TMEM127 [MIM# 613403] gene encodes the transmembrane protein 127. Heterozygous germline loss of function variants in TMEM127 were first described in 2005 [Dahia PL, et al.; PMID 16266984]. The LOH (loss of heterozygosity) at the TMEM127 locus in tumors examined suggests TMEM127 is a tumor suppressor gene. Genetic evidence from studies on familial and patients with sporadic Pheochromocytomas, as well as RCC are used in this curation [PMID 16266984, 25389632, 20154675 and 28384794]. Experimental evidences such as reduced TMEM127 transcription levels of TMEM127-mutant tumor samples in Pheochromocytomas and Renal cell carcinomas; reduced mTOR signaling, enlarged cells, reduced vesicles and/or increased cell growth compared to non mutant controls in various human cells and murine model cells with reduced or depleted TMEM127 are included for this curation. Evidence that the enlarged cells and increased cell proliferation were rescued by enforced expression of TMEM127 is also included [PMID 20154675, 21156949, 24334765]. In summary, TMEM127 gene is definitely associated with autosomal dominant HPGL/PCC syndrome, most commonly pheochromocytoma. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AD
Disease ID:MONDO:0008233
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0005086
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Oncologic
Intervention: Oncologic
Rationale: Surveillance and awareness of cancer risk may allow early diagnosis and treatment of neoplasms, which may reduce morbidity and mortality
Comments: Although adults have been reported, surveillance in the pediatric period may nevertheless be warranted
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TMEM127 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017849.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 259 | 263 | |||
| missense | 8 | 617 | 11 | 1 | 637 | |
| nonsense | 16 | 13 | 6 | 35 | ||
| start loss | 7 | 2 | 2 | 11 | ||
| frameshift | 57 | 20 | 6 | 83 | ||
| splice donor/acceptor (+/-2bp) | 5 | 9 | 3 | 17 | ||
| Total | 85 | 52 | 638 | 270 | 1 | 1046 |
Highest pathogenic variant AF is 0.000016379108
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060319.1 | 3 | MANE Select | |
| Ensembl | ENSP00000258439.3 | 3 | MANE Select | |
| RefSeq | NP_001180233.1 | 3 | Standard | |
| RefSeq | NP_001394211.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- endosome organization
- negative regulation of cell population proliferation
- negative regulation of TOR signaling
Molecular Function
- molecular_function
- Rab GTPase binding
Cellular Component
- cytoplasm
- early endosome
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000258439
- Coding exons
- 3
- Length
- 17479
- Individuals with no LoFs
- 125736
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 12
- Defined
- 125748
- p
- 0.0000477
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.448 | 123 | 138 | 0.893 | 0.00000808 | 1489 |
| Missense (PolyPhen) | 35 | 43.27 | 0.80887 | 495 | ||
| Synonymous | -0.112 | 66 | 64.9 | 1.02 | 0.00000398 | 531 |
| Loss of Function | 1.29 | 4 | 7.92 | 0.505 | 3.41e-7 | 96 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000062 | 0.000062 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Controls cell proliferation acting as a negative regulator of TOR signaling pathway mediated by mTORC1. May act as a tumor suppressor. {ECO:0000269|PubMed:20154675}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.116
- RVIS EVS
- -0.05
- RVIS percentile EVS
- 49.76
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.666
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |